Renaissance Technologies’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-219,328
Closed -$899K 4700
2022
Q1
$899K Buy
+219,328
New +$899K ﹤0.01% 2797
2021
Q4
Sell
-303,128
Closed -$1.1M 4350
2021
Q3
$1.1M Buy
+303,128
New +$1.1M ﹤0.01% 2494
2020
Q4
Sell
-339,213
Closed -$916K 3835
2020
Q3
$916K Buy
339,213
+101,685
+43% +$275K ﹤0.01% 2561
2020
Q2
$653K Sell
237,528
-1,129,086
-83% -$3.1M ﹤0.01% 2765
2020
Q1
$3.23M Buy
1,366,614
+221,907
+19% +$524K ﹤0.01% 1809
2019
Q4
$5.38M Buy
1,144,707
+1,016,579
+793% +$4.78M ﹤0.01% 1806
2019
Q3
$429K Sell
128,128
-196,200
-60% -$657K ﹤0.01% 2924
2019
Q2
$1.07M Sell
324,328
-88,500
-21% -$291K ﹤0.01% 2646
2019
Q1
$1.25M Buy
+412,828
New +$1.25M ﹤0.01% 2567
2018
Q1
Sell
-599,769
Closed -$1.19M 3655
2017
Q4
$1.19M Sell
599,769
-2,184,222
-78% -$4.35M ﹤0.01% 2595
2017
Q3
$9.02M Sell
2,783,991
-678,478
-20% -$2.2M 0.01% 1397
2017
Q2
$11.1M Buy
3,462,469
+309,900
+10% +$998K 0.01% 1216
2017
Q1
$8.95M Buy
3,152,569
+293,228
+10% +$833K 0.01% 1313
2016
Q4
$6.66M Buy
2,859,341
+185,000
+7% +$431K 0.01% 1483
2016
Q3
$4.49M Sell
2,674,341
-43,511
-2% -$73.1K 0.01% 1665
2016
Q2
$2.85M Buy
2,717,852
+486,683
+22% +$511K 0.01% 1977
2016
Q1
$1.94M Buy
2,231,169
+845,731
+61% +$736K ﹤0.01% 2237
2015
Q4
$1.68M Buy
1,385,438
+1,096,397
+379% +$1.33M ﹤0.01% 2215
2015
Q3
$491K Buy
289,041
+106,100
+58% +$180K ﹤0.01% 2637
2015
Q2
$381K Buy
+182,941
New +$381K ﹤0.01% 2803
2015
Q1
Sell
-85,970
Closed -$221K 3406
2014
Q4
$221K Sell
85,970
-59,758
-41% -$154K ﹤0.01% 2665
2014
Q3
$267K Buy
+145,728
New +$267K ﹤0.01% 2506